Cargando…
Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
The rapidly spreading outbreak of COVID-19 disease is caused by the SARS-CoV-2 virus, first reported in December 2019 in Wuhan, China. As of June 17, 2020, this virus has infected over 8.2 million people but ranges in symptom severity, making it difficult to assess its overall infection rate. There...
Autores principales: | Ravi, Neeraja, Cortade, Dana L., Ng, Elaine, Wang, Shan X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368663/ https://www.ncbi.nlm.nih.gov/pubmed/32729549 http://dx.doi.org/10.1016/j.bios.2020.112454 |
Ejemplares similares
-
EUA /
por: Suárez Argüello, Ana Rosa
Publicado: (1988) -
Laboratory-Based SARS-CoV-2 Receptor Binding Domain Serologic Assays Perform with Equivalent Sensitivity and Specificity to Commercial FDA-EUA Approved Tests
por: Nehring, Mary, et al.
Publicado: (2022) -
EUA : sus novelas
por: Rodríguez Alvarez, Argentina
Publicado: (1994) -
"Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit"
por: Freire-Paspuel, Byron, et al.
Publicado: (2020) -
EUA : historia de sus familias
por: Báez-Villaseñor, María Estela
Publicado: (1995)